부산대학교 도서관

Chau, C; Rimmer, Y; Choudhury, A; Leaning, D; Law, A; Enting, D; Lim, J H; Hafeez, S; Khoo, V; Huddart, R; Mitchell, D; Henderson, D R; McGrane, J; Beresford, M; Vasudev, N; Beesley, S; Hilman, S; Manetta, C; Sriram, R; Sharma, A; Eswar, C; Treece, S; Vilarino-Varela, M; Varughese, M; H Glen; Pintus, E; Crabb, S

Chau, C, Rimmer, Y, Choudhury, A, Leaning, D, Law, A, Enting, D, Kim, J H, Hafeez, S, Khoo, V, Huddart, R, Mitchell, D, Henderson, D, McGrane, J, Beresford, M, Vasudev, N, Beesley, S, Hilman, S, Manetta, C, Sriram, R, Sharma, A, Eswar, C, Treece, S, Vilarino-Varela, M, Varughese, M, Glen, H, Pintus, E & Crabb, S 2021, 'Treatment outcomes for small cell carcinoma of the bladder: results from a UK patient retrospective cohort study', International Journal of Radiation: Oncology-Biology-Physics.

Ince, L; Zhang, Z; Beesley, S; Vonslow, R; Saer, B; Matthews, L; Begley, N; Gibbs, J; Ray, D; Loudon, A

FASEB J
Ince, L, Zhang, Z, Beesley, S, Vonslow, R, Saer, B, Matthews, L C, Begley, N, Gibbs, J, Ray, D & Loudon, A 2018, 'Circadian variation in pulmonary inflammatory responses is independent of rhythmic glucocorticoid signalling in airway epithelial cells', Faseb Journal. https://doi.org/10.1096/fj.201800026RR

James, ND; Sydes, MR; Clarke, NW; Mason, MD; Dearnaley, DP; Spears, MR; Ritchie, AWS; Parker, CC; Russell, JM; Attard, G; de Bono, J; Cross, W; Jones, RJ; Thalmann, G; Amos, C; Matheson, D; Millman, R; Alzouebi, M; Beesley, S; Birtle, AJ; Brock, S; Cathomas, R; Chakraborti, P; Chowdhury, S; Cook, A; Elliott, T; Gale, J; Gibbs, S; Graham, JD; Hetherington, J; Hughes, R; Laing, R; McKinna, F; McLaren, DB; O'Sullivan, JM; Parikh, O; Peedell, C; Protheroe, A; Robinson, AJ; Srihari, N; Srinivasan, R; Staffurth, J; Sundar, S; Tolan, S; Tsang, D; Wagstaff, J; Parmar, MKB; STAMPEDE investigators

Lancet
Lancet (London, England), vol. 387, no. 10024, pp. 1163-1177
James, N D, Sydes, M R, Clarke, N W, Mason, M D, Dearnaley, D P, Spears, M R, Ritchie, A W S, Parker, C C, Russell, J M, Attard, G, de Bono, J, Cross, W, Jones, R J, Thalmann, G, Amos, C, Matheson, D, Millman, R, Alzouebi, M, Beesley, S, Birtle, A J, Brock, S, Cathomas, R, Chakraborti, P, Chowdhury, S, Cook, A, Elliott, T, Gale, J, Gibbs, S, Graham, J D, Hetherington, J, Hughes, R, Laing, R, McKinna, F, McLaren, D B, O'Sullivan, J M, Parikh, O, Peedell, C, Protheroe, A, Robinson, A J, Srihari, N, Srinivasan, R, Staffurth, J, Sundar, S, Tolan, S, Tsang, D, Wagstaff, J, Parmar, M K B & STAMPEDE Investigators 2016, 'Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial', Lancet, vol. 387, no. 10024, pp. 1163–1177. https://doi.org/10.1016/S0140-6736(15)01037-5
James, Nicholas D; Sydes, Matthew R; Clarke, Noel W; Mason, Malcolm D; Dearnaley, David P; Spears, Melissa R; Ritchie, Alastair W S; Parker, Christopher C; Russell, J Martin; Attard, Gerhardt; de Bono, Johann; Cross, William; Jones, Rob J; Thalmann, George; Amos, Claire; Matheson, David; Millman, Robin; Alzouebi, Mymoona; Beesley, Sharon; Birtle, Alison J; ... (2016). Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial. Lancet, 387(10024), pp. 1163-1177. Elsevier 10.1016/S0140-6736(15)01037-5
STAMPEDE Investigators 2016, 'Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE) : survival results from an adaptive, multiarm, multistage, platform randomised controlled trial', Lancet (London, England), vol. 387, no. 10024, pp. 1163-77. https://doi.org/10.1016/S0140-6736(15)01037-5

Gibbs, J E.; Beesley, S; Plumb, J; Singh, D; Farrow, S; Ray, D W.; Loudon, A S. I.

Endocrinology. Jan 01, 2009 150(1):268-276

Foley, M; Beesley, S; Cadden, E; Coakley, P; Doherty, C; Hendrick, P; Salami, A; Murphy, W G

Transfusion. Sep 01, 2005 45 Suppl s3:52A-52A

van As, NJ; Gilbert, DC; Money-Kyrle, J; Bloomfield, D; Beesley, S; Dearnaley, DP; Horwich, A; Huddart, RA

Br J Cancer

Andronis, L; Goranitis, I; Pirrie, S; Pope, A; Barton, D; Collins, S; Daunton, A; McLaren, D; O'Sullivan, JM; Parker, C; Porfiri, E; Staffurth, J; Stanley, A; Wylie, J; Beesley, S; Birtle, A; Brown, JE; Chakraborti, P; Hussain, SA; Russell, JM; Billingham, LJ; James, ND

Andronis, L, Goranitis, I, Pirrie, S, Pope, A, Barton, D, Collins, S, Daunton, A, McLaren, D, O'Sullivan, J M, Parker, C, Porfiri, E, Staffurth, J, Stanley, A, Wylie, J, Beesley, S, Birtle, A, Brown, J E, Chakraborti, P, Hussain, S A, Russell, J M, Billingham, L J & James, N D 2016, 'Cost-effectiveness of zoledronic acid and strontium-89 as bone protecting treatments in addition to chemotherapy in patients with metastatic castrate-refractory prostate cancer: results from the TRAPEZE trial (ISRCTN 12808747)', BJU International. https://doi.org/10.1111/bju.13549
Andronis, L, Goranitis, I, Pirrie, S, Pope, A, Barton, D, Collins, S, Daunton, A, McLaren, D, O'Sullivan, J M, Parker, C, Porfiri, E, Staffurth, J, Stanley, A, Wylie, J, Beesley, S, Birtle, A, Brown, J E, Chakraborti, P, Hussain, S A, Russell, J M, Billingham, L J & James, N D 2017, ' Cost-effectiveness of zoledronic acid and strontium-89 as bone protecting treatments in addition to chemotherapy in patients with metastatic castrate-refractory prostate cancer : results from the TRAPEZE trial (ISRCTN 12808747) ', BJU International, vol. 119, no. 4, pp. 522-529 . https://doi.org/10.1111/bju.13549

Clarke NW; Department of Urology, The Christie and Salford Royal NHS Foundation Trusts, Manchester. Electronic address: noel.clarke@christie.nhs.uk.; Ali A; Genito-Urinary Cancer Research Group, Division of Cancer Sciences, The University of Manchester, Manchester.; Ingleby FC; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London; London School of Hygiene and Tropical Medicine, London.; Hoyle A; Department of Urology, The Christie and Salford Royal NHS Foundation Trusts, Manchester.; Amos CL; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London.; Attard G; UCL Cancer Institute, London.; Brawley CD; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London.; Calvert J; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London.; Chowdhury S; Guy's and Saint Thomas' NHS Foundation Trust, London.; Cook A; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London.; Cross W; St James University Hospital, Leeds.; Dearnaley DP; Institute of Cancer Research, Sutton-London.; Douis H; Department of Radiology, University Hospitals Birmingham NHS Foundation Trust, Birmingham.; Gilbert D; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London.; Gillessen S; Division of Cancer Sciences, The University of Manchester, Manchester.; Jones RJ; Beatson West of Scotland Cancer Centre, University of Glasgow, Glasgow.; Langley RE; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London.; MacNair A; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London.; Malik Z; The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool.; Mason MD; Cardiff University, Cardiff.; Matheson D; Faculty of Education Health and Wellbeing, University of Wolverhampton, Wolverhampton.; Millman R; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London.; Parker CC; Institute of Cancer Research, Sutton-London; RoyalMarsden NHS Foundation Trust, London.; Ritchie AWS; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London.; Rush H; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London.; Russell JM; Institute of Cancer Sciences, Beatson West of Scotland Cancer Centre, Glasgow.; Brown J; University of Sheffield, Sheffield.; Beesley S; Kent Oncology Centre, Maidstone.; Birtle A; Lancashire Teaching Hospitals NHS Foundation Trust, Preston.; Capaldi L; Worcestershire Acute Hospitals NHS Trust, Worcester.; Gale J; Portsmouth Oncology Centre, Queen Alexandra Hospital, Portsmouth.; Gibbs S; Queen's Hospital, Romford.; Lydon A; Torbay and South Devon NHS Foundation Trust, Torbay.; Nikapota A; Sussex Cancer Centre, Brighton.; Omlin A; Department of Oncology and Haematology, Kantonsspital, St Gallen, Switzerland.; O'Sullivan JM; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK.; Parikh O; East Lancashire Hospitals NHS Trust, Blackburn, UK.; Protheroe A; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; Rudman S; Guy's and Saint Thomas' NHS Foundation Trust, London.; Srihari NN; Shrewsbury and Telford Hospital NHS Trust, Shrewsbury, UK.; Simms M; Hull and East Yorkshire Hospitals NHS Trust, Hull, UK.; Tanguay JS; Velindre Cancer Centre, Cardiff, UK.; Tolan S; The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool.; Wagstaff J; Swansea University College of Medicine, Swansea, UK.; Wallace J; Beatson West of Scotland Cancer Centre, University of Glasgow, Glasgow.; Wylie J; The Christie NHS Foundation Trust, Manchester, UK.; Zarkar A; Heartlands Hospital, Birmingham, UK.; Sydes MR; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London.; Parmar MKB; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London.; James ND; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE; PubMed not MEDLINE

Clarke NW; Department of Urology, The Christie and Salford Royal NHS Foundation Trusts, Manchester. Electronic address: noel.clarke@christie.nhs.uk.; Ali A; Genito-Urinary Cancer Research Group, Division of Cancer Sciences, The University of Manchester, Manchester.; Ingleby FC; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London; London School of Hygiene and Tropical Medicine, London.; Hoyle A; Department of Urology, The Christie and Salford Royal NHS Foundation Trusts, Manchester.; Amos CL; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London.; Attard G; UCL Cancer Institute, London.; Brawley CD; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London.; Calvert J; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London.; Chowdhury S; Guy's and Saint Thomas' NHS Foundation Trust, London.; Cook A; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London.; Cross W; St James University Hospital, Leeds.; Dearnaley DP; Institute of Cancer Research, Sutton-London.; Douis H; Department of Radiology, University Hospitals Birmingham NHS Foundation Trust, Birmingham.; Gilbert D; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London.; Gillessen S; Division of Cancer Sciences, The University of Manchester, Manchester.; Jones RJ; Beatson West of Scotland Cancer Centre, University of Glasgow, Glasgow.; Langley RE; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London.; MacNair A; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London.; Malik Z; The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool.; Mason MD; Cardiff University, Cardiff.; Matheson D; Faculty of Education Health and Wellbeing, University of Wolverhampton, Wolverhampton.; Millman R; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London.; Parker CC; Institute of Cancer Research, Sutton-London; Royal Marsden NHS Foundation Trust, London.; Ritchie AWS; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London.; Rush H; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London.; Russell JM; Institute of Cancer Sciences, Beatson West of Scotland Cancer Centre, Glasgow.; Brown J; University of Sheffield, Sheffield.; Beesley S; Kent Oncology Centre, Maidstone.; Birtle A; Lancashire Teaching Hospitals NHS Foundation Trust, Preston.; Capaldi L; Worcestershire Acute Hospitals NHS Trust, Worcester.; Gale J; Portsmouth Oncology Centre, Queen Alexandra Hospital, Portsmouth.; Gibbs S; Queen's Hospital, Romford.; Lydon A; Torbay and South Devon NHS Foundation Trust, Torbay.; Nikapota A; Sussex Cancer Centre, Brighton.; Omlin A; Department of Oncology and Haematology, Kantonsspital, St Gallen, Switzerland.; O'Sullivan JM; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast.; Parikh O; East Lancashire Hospitals NHS Trust, Blackburn.; Protheroe A; Oxford University Hospitals NHS Foundation Trust, Oxford.; Rudman S; Guy's and Saint Thomas' NHS Foundation Trust, London.; Srihari NN; Shrewsbury and Telford Hospital NHS Trust, Shrewsbury.; Simms M; Hull and East Yorkshire Hospitals NHS Trust, Hull.; Tanguay JS; Velindre Cancer Centre, Cardiff.; Tolan S; The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool.; Wagstaff J; Swansea University College of Medicine, Swansea.; Wallace J; Beatson West of Scotland Cancer Centre, University of Glasgow, Glasgow.; Wylie J; The Christie NHS Foundation Trust, Manchester.; Zarkar A; Heartlands Hospital, Birmingham.; Sydes MR; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London.; Parmar MKB; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London.; James ND; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

James, ND; Pirrie, SJ; Pope, AM; Barton, D; Andronis, L; Goranitis, I; Collins, S; Daunton, A; McLaren, D; O'Sullivan, J; Parker, C; Porfiri, E; Staffurth, J; Stanley, A; Wylie, J; Beesley, S; Birtle, A; Brown, J; Chakraborti, P; Hussain, S; Russell, M; Billingham, LJ

JAMA Oncology. 2:493

Tulikangas PK; Minimally Invasive Surgery Center, The Cleveland Clinic Foundation, Ohio 44195, USA. tulikap@ccf.org; Beesley S; Boparai N; Falcone T

Publisher: Elsevier for the American Society for Reproductive Medicine Country of Publication: United States NLM ID: 0372772 Publication Model: Print Cited Medium: Print ISSN: 0015-0282 (Print) Linking ISSN: 00150282 NLM ISO Abbreviation: Fertil Steril Subsets: MEDLINE

Cooley C; University of Central England.; Adeodu S; Aldred H; Beesley S; Leung A; Thacker L

Publisher: MA Healthcare Country of Publication: England NLM ID: 9506762 Publication Model: Print Cited Medium: Print ISSN: 1357-6321 (Print) Linking ISSN: 13576321 NLM ISO Abbreviation: Int J Palliat Nurs

Beesley S; Maurice J

Publisher: Seattle Treatment Education Project Country of Publication: United States NLM ID: 9888939 Publication Model: Print Cited Medium: Print NLM ISO Abbreviation: STEP Perspect

Beesley S; Chicken Soup Brigade, Seattle, WA.; Maurice J

Publisher: Seattle Treatment Education Project Country of Publication: United States NLM ID: 9888939 Publication Model: Print Cited Medium: Print NLM ISO Abbreviation: STEP Perspect

Beesley S; Mutrie N

Publisher: British Medical Association Country of Publication: England NLM ID: 8900488 Publication Model: Print Cited Medium: Print ISSN: 0959-8138 (Print) Linking ISSN: 09598138 NLM ISO Abbreviation: BMJ Subsets: MEDLINE

Beesley S; Chicken Soup Brigade, Seattle, WA.; Maurice J

Publisher: Seattle Treatment Education Project Country of Publication: United States NLM ID: 9888939 Publication Model: Print Cited Medium: Print NLM ISO Abbreviation: STEP Perspect

Beesley S; Department of Psychological Medicine, Gartnaval Royal Hospital, Glasgow.; Russell A

Publisher: Sage Country of Publication: Scotland NLM ID: 2983335R Publication Model: Print Cited Medium: Print ISSN: 0036-9330 (Print) Linking ISSN: 00369330 NLM ISO Abbreviation: Scott Med J Subsets: MEDLINE

Maurice J; University of Washington, Madison Clinic, Seattle, WA.; Beesley S

Publisher: Seattle Treatment Education Project Country of Publication: United States NLM ID: 9888939 Publication Model: Print Cited Medium: Print NLM ISO Abbreviation: STEP Perspect

Foley, M; Beesley, S; Cadden, E; Coakley, P; Doherty, C; Hendrick, P; Salami, A; Murphy, WG

TRANSFUSION; SEP 2005, 45 3, p52A-p52A, 1p. Supplement: S

Kumar, D; Beesley, S; Lombos, N; Mansour, D; Tafari, N

PEDIATRIC RESEARCH; APR 2002, 51 4, p410A-p410A, 1p. Supplement: S